Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency scid)
Authors:
- 1 October 1991
- journal article
- case report
- Published by Springer Nature in Pediatric Radiology
- Vol. 21 (6) , 447-448
Abstract
Adenosine deaminase (ADA) deficiency may manifest as severe combined immunodeficiency (SCID) in early infancy. Some of these children develop radiologic changes which may be in part related to effects of this enzyme deficiency on the bony epiphysis [1]. We describe the radiologic changes in a neonate with ADA deficiency and their resolution with polyethylene glycol conjugated adenosine deaminase (PEGADA, ADAGEN; Enzon, Inc., South Plainfield, NJ) enzyme replacement therapy.Keywords
This publication has 5 references indexed in Scilit:
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987
- Inherited enzyme deficiencies and immunodeficiency: Adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficienciesClinical Immunology and Immunopathology, 1986
- PATHOLOGIC FINDINGS IN ADENOSINE-DEAMINASE-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY .1. KIDNEY, ADRENAL, AND CHONDRO-OSSEOUS TISSUE ALTERATIONS1985
- Adenosine deaminase deficiency: Frequency and comparative pathology in autosomally recessive severe combined immunodeficiencyClinical Immunology and Immunopathology, 1979
- The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiencyThe Journal of Pediatrics, 1976